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Jodie M Dodd1,2*, Cecelia O’Brien1,2 and Rosalie M Grivell1,2Abstract
Pre-eclampsia is a common pregnancy related condition, which contributes significantly both to maternal and
perinatal morbidity and mortality. The precise pathophysiology of pre-eclampsia is uncertain, and the development
of effective preventive strategies remains elusive.
Schoenaker and colleagues conducted a systematic review and meta-analysis of observational studies reporting
dietary intake and dietary patterns. The findings indicated that women with a low dietary calcium intake were more
likely to be diagnosed with gestational hypertension, while there was a suggestion (although not statistically significant)
of a beneficial effect of a diet rich in fruits and vegetables on risk of pre-eclampsia.
This is in contrast to the findings of systematic reviews and meta-analyses of randomised trials in pregnancy evaluating
calcium supplementation and anti-oxidant vitamin C and E supplementation.
The validity of any systematic review is reliant on both the underlying methodology and the quality of each of the
included studies; the review by Schoenaker and colleagues is limited by the observational nature of the included studies.
Please see related article: http://www.biomedcentral.com/1741-7015/12/157/abstract.
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Pre-eclampsia is a condition specific to the second half
of pregnancy, affecting multiple organ systems, [1] and
affecting approximately 2% to 8% of pregnant women
[2]. While the condition is more commonly encountered
among women in their first ongoing pregnancy, there are
a number of additional recognised risk factors, including a
past history of pre-eclampsia, underlying essential hyper-
tension, the coexistence of autoimmune conditions and
multi-fetal pregnancies [3]. While the incidence of disease
risk factors has steadily increased, particularly an increase
in maternal age at the time of first pregnancy and an
increase in maternal obesity [3], the actual incidence of
pre-eclampsia has decreased, reflecting, in part, a trend
to an earlier gestational age at birth [4].* Correspondence: jodie.dodd@adelaide.edu.au
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World-wide, hypertension during pregnancy contributes
significantly to both maternal and perinatal mortality
and morbidity [4-6], accounting for 10% to 15% of all direct
maternal deaths [7]. The vast majority of maternal deaths
attributable to pre-eclampsia occur in low to middle in-
come countries [8], although the proportional contribution
to direct maternal deaths in high income countries remains
similar [9,10]. Pre-eclampsia is a contributing factor in up
to one third of all cases of serious maternal morbidity, with
5% of women with severe disease requiring admission to
intensive care [11,12], and in the longer-term, increases a
woman’s risk of both chronic hypertension and cardio-
vascular disease [13,14].
Pre-eclampsia associated perinatal morbidity and mortality
Independent of the effects of both prematurity and
intra-uterine growth restriction, pre-eclampsia is a con-
tributing factor in up to 2.7% of all perinatal deaths [15].
Furthermore, pre-eclampsia is documented as an ante-
cedent factor in up to 12% of infants born with intra-
uterine growth restriction [16] and 19% born preterm
[17]. Both prematurity and small for gestational age aretd. This is an Open Access article distributed under the terms of the Creative
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including respiratory distress syndrome, feeding difficulties,
hypoglycaemia, seizures, intracranial haemorrhage and
prolonged hospitalisation [18]. In the longer-term, preterm
and small for gestational age infants remain at increased
risk of neurodevelopmental delay in childhood [19], and
subsequent obesity, insulin resistance and cardiovascular
disease in later life [20].
Strategies to prevent pre-eclampsia: are dietary strategies
the key?
The recent systematic review and meta-analysis by
Schoenaker and colleagues [21] reports an association
between gestational hypertensive conditions, including
pre-eclampsia, and dietary factors, based on observational
studies. The review inclusion criteria were studies where
energy intake, nutrient intake, food groups, or overall dietary
patterns, either alone or in combination with dietary supple-
ments, were reported, but excluded purely supplement-
based studies. The findings of the review indicated that
women with a low dietary calcium intake were more likely
to be diagnosed with gestational hypertension, and while
there were no significant associations between dietary
content of vitamins C and E, vitamin D and n-3 poly-
unsaturated fatty acids with pre-eclampsia, there was a sugges-
tion (although not statistically significant) of a beneficial effect
of a diet rich in fruits and vegetables on risk of pre-eclampsia.
How do these findings compare with the randomised
trial literature evaluating strategies for the prevention
of pre-eclampsia?
In general terms, the development of effective strategies
for the prevention of pre-eclampsia has proven exceedingly
difficult [5], related in part to the uncertainty of the precise
‘cause’ of the condition [1], and its likely multifactorial and
complex nature. Many interventions have been proposed
and evaluated in the prevention of pre-eclampsia, although
low-dose aspirin [22] and calcium supplementation [23]
remain the only strategies associated with a definitive
reduction in risk. The use of antiplatelet agents has been as-
sociated with a 17% reduction in the risk of pre-eclampsia,
and a modest 8% and 10% reduction in both preterm birth
and small for gestational age infants, respectively [22]. While
calcium supplementation has been associated with a relative
risk reduction of 55% in pre-eclampsia, this appears to be
largely confined to women with low dietary calcium intake
[23]. Furthermore, the effects of calcium supplementation
on improving measures of infant health are less clear [23].
The review by Schoenaker and colleagues [21] demon-
strated no significant associations between dietary content
of vitamins C and E, vitamin D and n-3 polyunsaturated
fatty acids with pre-eclampsia. However, there was a sug-
gested potential beneficial effect from a diet rich in fruits
and vegetables, foods well recognised to be a richsource of vitamin C in particular. There has been con-
siderable research interest in supplementation with
anti-oxidant vitamins C and E as a potential strategy for
the prevention of pre-eclampsia. Unfortunately, however,
well conducted randomised trials and subsequent meta-
analyses have demonstrated no beneficial effect of anti-
oxidant vitamin supplementation in reducing a woman’s
risk of developing pre-eclampsia [24].
Why is there a discrepancy in findings?
Well-conducted systematic reviews and meta-analyses are
highly regarded as a reliable source of information in the
evidence hierarchy [25]. While the validity of any systematic
review is heavily dependent on the underlying methodology,
the certainty of the conclusions is limited by the quality of
each of the individual studies identified and included. The
review by Schoenaker and colleagues [21] is, therefore, lim-
ited by the observational nature of the included studies.
Observational studies are able to identify associations, but
randomised trials are required to evaluate cause and effect.
Furthermore, the majority of the included observational
studies utilised self-reported dietary questionnaires, which
are subject to recall bias, and most were not validated. Most
of the included studies did not adjust for important
confounding factors, including maternal age, parity and pre-
existing hypertension, all of which have been recognised to
increase a woman’s risk of gestational hypertension and pre-
eclampsia. There was substantial heterogeneity across the
studies, particularly in relation to women’s unadjusted cal-
cium and total daily energy intake. All of these factors limit
the confidence with which any conclusions can be made.
As Schoenaker and colleagues [21] highlight, there is a
need for well-powered prospective intervention studies to
evaluate the role of healthy dietary patterns in pregnancy
and their impact on maternal and infant health outcomes,
including gestational hypertension and pre-eclampsia. Such
a study would require a large sample size of the order of
several thousand pregnant women, and dietary intervention
studies are by necessity complex, difficult to conduct well
and difficult to evaluate. This reflects the fact that ‘diet’
itself is complex, and it is not only individual dietary
components that may impact disease pathophysiology,
but also their combination – we tend to eat ‘food’ rather
than individual macro- and micronutrients in isolation.
Conclusions
It has been stated that: ‘Evidence does not speak for
itself – it requires interpretation in light of its original con-
text (and) limitations…’ [26]. The findings of Schoenaker’s
systematic review [21] suggest a non-statistically significant
benefit in pregnant women adopting a healthy dietary pat-
tern. While acknowledging the limitations and observational
nature of the included studies, this would seem to be
prudent advice.
Dodd et al. BMC Medicine 2014, 12:176 Page 3 of 3
http://www.biomedcentral.com/1741-7015/12/176Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JMD produced the first draft of the manuscript; all authors provided critical
revision of the manuscript for important intellectual content. All authors read
and approved the final manuscript.
Acknowledgements
JM Dodd is supported through a NHMRC Practitioner Fellowship (ID 627005).
RM Grivell is supported through a NHMRC Early Career Fellowship (ID 1073514).
Received: 9 September 2014 Accepted: 9 September 2014
References
1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005, 365:785–799.
2. Geographic variation in the incidence of hypertension in pregnancy: World
Health Organization International Collaborative Study of Hypertensive
Disorders of Pregnancy. Am J Obstet Gynecol 1988, 158:80–83.
3. Wallis AB, Saftlas AF, Hsia J, Atrash HK: Secular trends in the rates of
preeclampsia, eclampsia, and gestational hypertension, United States,
1987-2004. Am J Hypertens 2008, 21:521–526.
4. Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S,
Gokhale M, Kotelchuck M, Melve KK, Langridge A, Morris C, Morris JM, Nassar N,
Norman JE, Norrie J, Sørensen HT, Walker R, Weir CJ: Population-based
trends in pregnancy hypertension and pre-eclampsia: an international
comparative study. BMJ Open 2011, 1:e000101.
5. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol
2009, 33:130–137.
6. Ronsmans C, Graham WJ, Lancet Maternal Survival Series steering group:
Maternal mortality: who, when, where, and why. Lancet 2006,
368:1189–1200.
7. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF: WHO analysis of
causes of maternal death: a systematic review. Lancet 2006, 367:1066–1074.
8. World Health Organization: The World Health Report 2005: Make Every Mother
and Child Count. Geneva: WHO; 2005.
9. Lewis G: The Confidential Enquiry into Maternal and Child Health (CEMACH):
Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer
2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths
in the United Kingdom. London: 2007.
10. Lewis G, Drife JO: Why Mothers Die 2000-2002: The Sixth Report on Confidential
Enquiries into Maternal Deaths in the United Kingdom. London: 2004.
11. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D,
MAGPIE Trial Collaborative Group: Do women with pre-eclampsia, and
their babies, benefit from magnesium sulphate? The Magpie Trial:
a randomised placebo-controlled trial. Lancet 2002, 359:1877–1890.
12. National Insitute for Health Care Excellence: Hypertension in Pregnancy: The
Management of Hypertensive Disorders during Pregnancy. London: 2010.
13. Bellamy L, Casas JP, Hingorani AD, Williams DJ: Pre-eclampsia and risk of
cardiovascular disease and cancer in later life: systematic review and
meta-analysis. BMJ 2007, 335:974.
14. Fisher KA, Lugar A, Spargo BH, Lindeheimer MD: Hypertension in
pregnancy: Clinical-pathological correlations and remote prognosis.
Medicine (Baltimore) 1981, 60:267–276.
15. Laws PJ, Li Z, Sullivan EA: Australia’s Mothers and Babies 2008. Australian
Institute of Health and Welfare; 2010.
16. Kramer MS, Séguin L, Lydon J, Goulet L: Socio-economic disparities in
pregnancy outcome: why do the poor fare so poorly? Paediatr Perinat
Epidemiol 2000, 14:194–210.
17. Hewitt BG, Newnham JP: A review of the obstetric and medical
complications leading to the delivery of infants of very low birthweight.
Med J Aust 1988, 149:234.
18. Saigal S, Doyle LW: An overview of mortality and sequelae of preterm
birth from infancy to adulthood. Lancet 2008, 371:261–269.
19. Strauss RS: Adult functional outcome of those born small for gestational
age. Twenty-six year follow up of the 1970 British Birth Cohort. JAMA
2000, 283:625–632.
20. Barker DJ: Mothers, Babies and Disease in Later Life. 2nd edition. London:
Harcourt Brace & Co; 1998.
21. Schoenaker: 2014.22. Duley L, Henderson-Smart DJ, Meher S, King JF: Antiplatelet agents for
preventing pre-eclampsia and its complications. Cochrane Database Syst
Rev 2007, 2, CD004659.
23. Hofmeyr GJ, Atallah AN, Duley L: Calcium supplementation during
pregnancy for preventing hypertensive disorders and related problems.
Cochrane Database Syst Rev 2010, 8, CD001059.
24. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P,
Hauguel-de Mouzon S: Maternal interleukin-6: marker of fetal growth and
adiposity. J Soc Gynecol Investig 2006, 13:53–57.
25. National Health and Medical Research Council: NHMRC Evidence
Hierarchy: designations of ‘levels of evidence’ for intervention studies.
In NHMRC levels of evidence and grades for recommendations. 2009.
26. Cook DA: Randomized controlled trials and meta-analysis in medical
education: What role do they play? Med Teach 2012, 34:468–473.
doi:10.1186/s12916-014-0176-4
Cite this article as: Dodd et al.: Preventing pre-eclampsia – are dietary
factors the key? BMC Medicine 2014 12:176.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
